Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2009;105:375-382
Published online before print July 9, 2009, doi: 10.1161/CIRCRESAHA.109.196055
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
105/4/375    most recent
CIRCRESAHA.109.196055v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Carballo, S.
Right arrow Articles by Watkins, H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carballo, S.
Right arrow Articles by Watkins, H.
Related Collections
Right arrow Contractile function
Right arrow Myocardial cardiomyopathy disease
Right arrowRelated Article
(Circulation Research. 2009;105:375.)
© 2009 American Heart Association, Inc.


Clinical Research

Identification and Functional Characterization of Cardiac Troponin I As a Novel Disease Gene in Autosomal Dominant Dilated Cardiomyopathy

Sebastian Carballo, Paul Robinson, Robyn Otway, Diane Fatkin, Jan D.H. Jongbloed, Nicolaas de Jonge, Edward Blair, J. Peter van Tintelen, Charles Redwood, Hugh Watkins

From the Department of Cardiovascular Medicine (S.C., P.R., E.B., C.R., H.W.), University of Oxford, Wellcome Trust Centre for Human Genetics, Oxford United Kingdom; Victor Chang Cardiac Research Institute and St Vincent’s Hospital (R.O., D.F.), Darlinghurst, Australia; Faculties of Medicine and Science (D.F.), University of New South Wales, Kensington, Australia; Department of Genetics (J.D.H.J., J.P.v.T.), University Medical Center Groningen, University of Groningen, The Netherlands; and Department of Cardiology (N.d.J.), Division of Heart and Lungs, University Medical Center Utrecht, The Netherlands.

Correspondence to Prof Hugh Watkins, Department of Cardiovascular Medicine, University of Oxford, Level 6 West Wing, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom. E-mail hugh.watkins{at}cardiov.ox.ac.uk

Rationale: Idiopathic dilated cardiomyopathy (DCM) is inherited in approximately one third of cases, usually as an autosomal dominant trait. More than 30 loci have been identified, several of which encode sarcomeric proteins which can also be mutated to cause hypertrophic cardiomyopathy. One contractile protein gene well known as a hypertrophic cardiomyopathy disease gene, but with no reported mutation in autosomal dominant DCM, is TNNI3 which encodes cardiac troponin I.

Objective: To test TNNI3 as a candidate gene, a panel of 96 probands with DCM was analyzed.

Methods and Results: Genomic DNA was isolated and TNNI3 exons screened by heteroduplex analysis. Exons with aberrant profiles were sequenced and variants evaluated by segregation analysis and study of normal controls. We report 2 novel TNNI3 missense mutations, Lys36Gln and Asn185Lys, each associated with severe and early onset familial DCM. Of the 5 mutation carriers, cardiac transplantation was required in 3, at ages 6, 15, and 24 years. Analysis of Ca2+ regulation of actin-tropomyosin–activated myosin ATPase by troponin revealed that troponin reconstituted with either mutant troponin I gave lower maximum ATPase rates and lower Ca2+ sensitivity than wild type. Furthermore, mutant thin filaments had reduced Ca2+ affinity compared with normal.

Conclusions: The functional alterations mirror closely a consistent phenotype found in proven DCM mutations in other thin filament proteins, thus supporting the interpretation that these mutations are disease-causing. These are the first reported autosomal dominant DCM-causing mutations in TNNI3, and so the findings expand the spectrum of disease-causing genes that lead to either hypertrophic cardiomyopathy or DCM depending on the specific mutation.


Key Words: Ca2+ regulation • cardiomyopathy • contractility • dilated cardiomyopathy • mutation


Related Article:

Expanded Spectrum of Gene Causing Both Hypertrophic Cardiomyopathy and Dilated Cardiomyopathy
Sachio Morimoto
Circ. Res. 2009 105: 313-315. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Circ. Res.Home page
S. Morimoto
Expanded Spectrum of Gene Causing Both Hypertrophic Cardiomyopathy and Dilated Cardiomyopathy
Circ. Res., August 14, 2009; 105(4): 313 - 315.
[Full Text] [PDF]